Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease

Min-Sun Kim1, Eun-Kyung Kim1, Joon Young Choi2

  • 1Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular and Stroke Institute Imaging Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

Insights

Diagnosing pericardial disease is difficult, but [18F]FDG-PET/CT imaging can help. This technique visualizes inflammation and malignancy, aiding in treatment planning and prognosis for pericardial conditions.

Area of Science:

  • Nuclear Medicine
  • Cardiology
  • Oncology

Background:

  • Pericardial disease diagnosis is challenging due to limited access to pericardial fluid and tissue.
  • Pericardial disease can be an early sign of systemic diseases, necessitating accurate etiological identification.
  • Early detection and management of pericarditis are crucial to prevent long-term complications.

Purpose of the Study:

  • To review the clinical utility of [18F]-2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) for diagnosing and managing pericardial disease.
  • To assess the role of [18F]FDG-PET/CT in differentiating between inflammatory and neoplastic causes of pericardial disease.
  • To evaluate the potential of [18F]FDG-PET/CT in guiding anti-inflammatory treatment strategies.

Main Methods:

  • Review of existing literature on [18F]FDG-PET/CT applications in pericardial disease.
  • Analysis of [18F]FDG-PET/CT imaging characteristics in various pericardial conditions.
  • Correlation of imaging findings with clinical outcomes and treatment responses.

Main Results:

  • [18F]FDG-PET/CT effectively visualizes hypermetabolic activity in the pericardium, indicative of inflammation or malignancy.
  • The pattern of [18F]FDG uptake can help distinguish neoplastic from inflammatory etiologies.
  • High pericardial [18F]FDG uptake, after excluding malignancy, suggests active inflammation and predicts response to anti-inflammatory therapy.

Conclusions:

  • [18F]FDG-PET/CT is a valuable tool for the diagnosis of pericardial disease, offering insights into etiology.
  • The imaging modality aids in establishing prognosis and planning targeted anti-inflammatory treatments.
  • [18F]FDG-PET/CT can potentially improve patient outcomes by enabling precise management of pericardial conditions.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
574
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
720
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
512
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
367
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
550